Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anabolic therapies.

R Marcus1

  • 1Geriatrics Research, Education, and Clinical Center, VA Palo Alto Health Care System, California, USA.

Clinics in Laboratory Medicine
|September 15, 2000
PubMed
Summary
This summary is machine-generated.

Anabolic therapies show promise for osteoporosis treatment. Parathyroid hormone may offer significant antifracture benefits, while human growth hormone and fluoride have limited or uncertain efficacy for fracture prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What do South African adolescents want in a sexual health service? Evidence from the South African Studies on HIV in Adolescents (SASHA) project.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018
Same author

Comments on Galli et al.: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.

Bone marrow transplantation·2017
Same author

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

Leukemia & lymphoma·2016
Same author

Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.

International journal of clinical practice·2014
Same author

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Area of Science:

  • Bone research
  • Endocrinology
  • Pharmacology

Background:

  • Osteoporosis therapy seeks effective anabolic agents.
  • Current treatments focus on antiresorptive drugs and preventive measures.

Purpose of the Study:

  • To evaluate the potential of anabolic therapies for osteoporosis.
  • To assess the efficacy of parathyroid hormone, human growth hormone, and fluoride in bone health.

Main Methods:

  • Review of preliminary evidence and clinical data.
  • Analysis of bone mineral density and antifracture efficacy.

Main Results:

  • Parathyroid hormone shows potential for antifracture efficacy.
  • Human growth hormone demonstrates limited anabolic promise for bone.

Related Experiment Videos

  • Fluoride increases bone mineral density but fracture prevention is debated.

    • Conclusions:

    • Parathyroid hormone may become a valuable addition to osteoporosis treatment.
    • Preventive measures and antiresorptive drugs will likely remain central to therapy.
    • Further research is needed to confirm antifracture efficacy of emerging anabolic agents.